Transmission of Multidrug-Resistant Salmonella enterica Subspecies enterica 4,[5],12:i:- Sequence Type 34 between Europe and the United States

Multidrug-resistant Salmonella enterica subspecies enterica 4,[5],12:i:- sequence type 34 represents a worldwide public health risk. To determine its origin in the United States, we reconstructed a time-scaled phylogeny with a discrete trait geospatial model. The clone in the United States was introduced from Europe on multiple occasions in the early 2000s.     

Service learning: a strategy for conducting a health needs assessment of the homeless

An agency providing health care services for homeless persons and a nursing department at a liberal arts college established a service-learning partnership to complete a health needs assessment of homeless persons. Under the guidance of agency staff and a nursing faculty member, seven nursing students surveyed shelter residents (n = 101) in four urban shelters and conducted a focus group to identify residents' perceptions of health, health care needs, and health care service delivery. The service-learning partnership expanded the agency's services by providing research consultation and data collection that resulted in recommendations to improve health care services for the homeless. The agency contributed to the education of health professionals by providing students with a meaningful community service experience.     

Risk Factors for Mild Cognitive Impairment,Dementia and Mortality: The Sydney Memory and Ageing Study

Background

The nature and commonality of late-life risk factors for mild cognitive impairment (MCI), dementia, and mortality remain unclear. Our aim was to investigate potential risk factors, simultaneously in a single cohort including many individuals initially with normal cognition and followed for 6 years.

A method for the evaluation of dose-toxicity relationships in clinical trials

This paper considers a proportional hazards model that describes the relationship between time-dependent cumulative dose of drug and development of toxicity. We estimate probabilities of developing toxicity in both the presence and the absence of competing risks and provide variances for the latter case. Mitoxantrone data collected in Southwest Oncology Group studies illustrate the methods.     

Effect of the aldose reductase inhibitor, ponalrestat, on diabetic neuropathy

The effect of treatment with the aldose reductase inhibitor, Ponalrestat*, was studied in 30 diabetic patients with established peripheral and autonomic neuropathy. After a 4-week placebo run-in phase, patients were randomised to 16 weeks active or placebo treatment in a double-blind, parallel-group trial. Changes in neuropathy were assessed using vibration perception thresholds, heart rate responses to deep breathing, pulse and blood pressure changes on standing and the patients' subjective scoring of peripheral and autonomic neuropathic symptoms. In addition, circulating neuropeptides and the responses of circulating gut peptides to an oral glucose tolerance test were studied. There was a significant improvement in the mean vibration perception threshold over the four sites studied in the ponalrestat treated group. There were no significant changes in the other indices of neuropathy, including heart rate variability, blood pressure responses to standing or symptom scores, though there were trends towards improvement. There were no significant changes in the levels of the circulating neuropeptides or in the responses of the circulating gut peptides to oral glucose tolerance test. No clinically important side-effects attributable to ponalrestat were observed. We conclude that ponalrestat improves some of the parameters of diabetic neuropathy and is likely to be of value in the treatment of this condition.     

Reduction-mediated technetium-99m labeling of monoclonal antibodies

A simple and generally applicable method for labeling antibodies with technetium-99m (99mTc) is described. Following reduction of intrinsic disulphide bonds, the antibody is labeled with 99mTc in the presence of a weak competing ligand methylene diphosphonate. High labeling efficiencies (greater than 97%), in a final labeling step taking only a few minutes, can be routinely obtained with high in-vitro stability over 24 hr. No effect upon antibody reactivity is seen.     

Concurrent Borrelia burgdorferi and Babesia microti infection in nymphal Ixodes dammini.

Ixodes dammini nymphs were examined for evidence of concurrent infection with Borrelia burgdorferi and Babesia microti. A total of 19 nymphs (18.6%) from Nantucket Island were simultaneously infected, as were 24 nymphs (8.2%) from Naushon Island. These observations are consistent with a common reservoir host for both I. dammini-transmitted pathogens.